15159018Suckow MA, Gutierrez LS, Risatti CA, Wolter WR, Taylor RE, Pollard M, Navari RM, Castellino FJ, Paoni NFCancer lettersAdenomatous Polyposis Coli; Carcinogens; Enzyme Inhibitors; Intestinal Neoplasms; PiperazinesAcetanilides; Alleles; Animals; Disease Progression; Dose-Response Relationship, Drug; Genes, APC; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Invasiveness; RanolazineThe anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice. Cancer Lett. 2004 Jun 25; 209(2):165-9.Cancer Lett2004-06-25T00:00:002004The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areaInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000083Chemicals & Drugs660.996926AcetanilidesD000483Genes & Molecular Sequences29311270.757194AllelesD000818Living Beings1457265180.249624AnimalsD002273Chemicals & Drugs541080.953418CarcinogensD007274Procedures661020.976138Injections, IntraperitonealD004791Chemicals & Drugs2686320.779731Enzyme InhibitorsD004305Concepts & Ideas52019580.724084Dose-Response Relationship, DrugD008810Living Beings55730870.60566Mice, Inbred C57BLD007414Disorders34560.941055Intestinal NeoplasmsAuthorship 249107D010879Chemicals & Drugs1102720.858215PiperazinesD008297Physiology1931408600.201617Male0.06356460.06356461authors10.2518has subject areaD017491Genes & Molecular Sequences19260.975694Genes, APCD018345Living Beings43819180.695188Mice, KnockoutD018450Physiology49815310.700842Disease ProgressionD051379Living Beings980113130.368397MiceD000069458440.999146RanolazineD009361Disorders2265510.854984Neoplasm InvasivenessD011125Disorders27390.968923Adenomatous Polyposis ColiUniversity of ChicagoRudolphNavariRudolph Navari41.78927490000000-87.601250000000001347Navari, Rudolphtrue1